Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:08 PM
Ignite Modification Date:
2025-12-24 @ 11:08 PM
NCT ID:
NCT01523769
Eligibility Criteria:
Inclusion Criteria:
* Singleton pregnancy
* Delivery anticipated between 24 and 28+6 weeks gestation
* There is enough time from admission to anticipated delivery to properly obtain consent from the patient
Exclusion Criteria:
* Multifetal gestation
* Antenatally diagnosed major congenital anomaly
* Known Rh sensitized pregnancy
* Hydrops fetalis (any etiology)
* Known positive maternal Parvovirus titers
* Elevated peak systolic velocity of the fetal Middle Cerebral Artery (MCA)
* Clinical suspicion of placental abruption at delivery due to excessive maternal bleeding or uterine hypertonicity
* Maternal age under 18
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT01523769
Study Brief:
Protocol Section:
NCT01523769